Our group (50) showed metformin and oxamate plus doxorubicin-induced late apoptosis, an increase of protein caspase-3, and a drop in PARP-1 in triple-negative breast cancer cells. This evidence concerns the gene PARP1 and triple-negative breast carcinoma.